INTRODUCTION
Muscarinic receptors, which are linked to a variety of intracellular second messenger systems through G-proteins, can be divided into five distinct subtypes (i.e., M " , M # , M $ , M % , and M & ), depending on their binding affinities for specific agonists and antagonists [1, 2] . Of the five muscarinic receptor subtypes, M " , M $ and M & are known to couple preferentially with phospholipase C (PLC), which induces phosphoinositide turnover [3] [4] [5] [6] . Hydrolysis of PtdIns leads to the formation of diacylglycerol and InsP $ , which may result in the activation of protein kinase C (PKC) and mobilization of Ca# + respectively [7] . These three receptors can also activate adenylate cyclase and ion channels [5, 6, 8] . On the other hand, activation of the other two subtypes, M # and M % , inhibits adenylate cyclase via G i -or G o -proteins and does not stimulate PLC [5] .
Stimulation of muscarinic receptors is also known to induce activation of mitogen-activated protein (MAP) kinase subtypes Erk-1 and -2 [9] [10] [11] . Activation of Erk by the stimulation of M # muscarinic receptor with carbachol is mediated by G βγ -dependent activation of phosphoinositide 3-kinase (PI 3-kinase) [9] . Signalling from PI 3-kinase to Erk requires a tyrosine kinase, adapter proteins Shc and Grb2, guanine-nucleotide exchange factor Sos, small GTPase Ras and serine\threonine protein kinase Raf. Similarly to M # muscarinic receptor, a stimulation of M $ muscarinic receptor with carbachol induces Erk activation [11, 12] . However, apart from the fact that PKC is required for Erk activation [11, 12] , the signalling pathway from M $ muscarinic receptor to Erk is not very well understood. The present study was undertaken to elucidate a signalling pathway leading to the activation of Erk-1 and -2 in human neuroblastoma SK-N-BE2(C) cells upon a stimulation of muscarinic receptor with Abbreviations used : MAP kinase, mitogen-activated protein kinase ; MEK, MAP kinase kinase ; MEKK, MEK kinase ; PI 3-kinase, phosphoinositide 3-kinase ; PLC, phospholipase C ; PKC, protein kinase C ; ECL2 enhanced chemiluminescence (Amersham). 1 To whom correspondence should be addressed (e-mail jschun!kyungpook.ac.kr) the serine\threonine protein kinase Raf, and an inhibition of Raf blocked Erk-1\-2 activation. Ectopic expression of inhibitory small GTPase Ras, RasN17, blocked the carbachol-induced Raf activation without affecting the activation of PKCε, while the inhibition of PKC blocked the Raf activation. Thus, these results suggest that carbachol-induced activation of PKCε mediates Erk-1\-2 activation by a sequential activation of Ras, Raf and MAP kinase kinase.
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carbachol. We report herein that PKCε mediates Ras, Raf, and MAP kinase kinase (MEK)-dependent activation of Erk-1 and -2 upon stimulation of M $ muscarinic receptor through a signalling pathway independent of the activity of PI 3-kinase.
EXPERIMENTAL

Cell culture
Human neuroblastoma SK-N-BE2(C) cells were grown in Dulbecco's modified Eagle's medium supplemented with 10 % (v\v) heat-inactivated bovine-calf serum, 50 µg\ml of streptomycin, and 50 units\ml of penicillin (Gibco-BRL, Gaithersburg, MD, U.S.A.) in a humidified atmosphere of air\CO # (19:1) at 37 mC as described previously [6] .
Mobility-shift assay of Erk
Activation of Erk-1 and -2 upon stimulation of cells with carbachol was examined by mobility-shift assay as described previously [13] . Briefly, total cell lysates were prepared by extracting proteins with 50 mM Tris, pH 7.4, containing 150 mM NaCl, 1 % Nonidet P40, 0.2 % SDS, 0.1 % deoxycholate, 10 µg\ml of leupeptin, 10 µg\ml of pepstatin A, 1 mM 4-(2-aminoethyl)benzenesulphonyl fluoride, 5 mM NaF, 1 mM sodium orthovanadate and 1 mM 4-nitrophenyl phosphate. The cell lysates were separated by 0.1 %-SDS\10 %-PAGE. Erk-1 and -2 were detected with antibodies purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, U.S.A.). Alternatively, activation of Erk-1 and -2 was examined by determining their phosphorylation using antibody specific to phosphorylated Erk-1 and -2 (New England Biolabs. Inc., Beverly, MA, U.S.A.). The blots were incubated with a peroxidase-conjugated secondary antibody, and proteins were revealed by the enhanced chemiluminescence (ECL2 ; Amersham) system. Relative amounts of phosphorylated Erk-1 or -2 were quantified by densitometry using X-ray film. 
Raf kinase assay
Cell fractionation
Separation of cytosolic and particulate membrane fractions was performed as described previously [13, 14] . SK-N-BE2(C) cells were scraped into buffer A (20 mM Tris\HCl, pH 7.5, containing 0.25 M sucrose, 2 mM EGTA, 2 mM EDTA and protease inhibitors as described above). The cells were sonicated twice for 5 s using microtips at 30 % of maximum power of the sonifier (Sonics and Materials Inc, Danbury, CT, U.S.A.) and centrifuged for 1 h at 100 000 g. The supernatant was designated ' cytosolic fraction '. The pellet was incubated with buffer B (20 mM Tris\HCl, pH 7.5, containing 1 % SDS, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA and protease inhibitors as described above). The incubation mixture was centrifuged for 15 min at 15 000 g, and the supernatant was saved as ' particulate membrane fraction '.
Western-blot analysis
Proteins (30 µg) separated by SDS\PAGE were transferred to nitrocellulose membrane, and the nitrocelluose sheet was incubated with 3 % (w\v) non-fat dry milk in Tris-buffered saline. PKC isoforms were detected with anti-PKC monoclonal antibodies specific for the β, δ, ε, θ, λ\ι, and µ isoforms (Transduction Laboratories, Lexington, KY, U.S.A.) or with polyclonal antibodies for α, γ, and ζ (Santa Cruz Biotechnology) and η (Biomol, Plymouth Meeting, PA, U.S.A.). panRas and c-Raf-1 were detected with antibodies purchased from Santa Cruz Biotechnology. The blots were incubated with a peroxidaseconjugated secondary antibody, and proteins were visualized by the ECL2 system [13, 15] .
Expression of RasN17
The expression vectors containing cDNA for the dominantnegative mutant of Ras, RasN17, have been described previously [16] . The expression vector was introduced into SK-N-BE2(C) cells using LipofectaminePLUS (Gibco-BRL) by the procedure recommended by the manufacturer. The transfected cells were cultured in complete medium for 24 h and were used for the assay of Erk-1\-2, Raf and PKC.
RESULTS
Carbachol activates Erk-1/-2 by the stimulation of M 3 muscarinic receptor in SK-N-BE2(C) cells
Activation of Erk-1\-2 by stimulating SK-N-BE2(C) cells with carbachol was examined either by mobility-shift assay or by determining phosphorylation using antibody specific to phosphorylated Erk-1 and -2. Both assay methods suggested an activation of Erk-1 and -2, as shown in Figures 1(A) and 1(B) . Therefore the mobility-shift assay was routinely employed in the following experiments. Carbachol-induced Erk activation was blocked when the cells were pretreated with non-specific antagonist of muscarinic receptors, such as 10 µM atropine ( Figure  2A ). Among the antagonists sensitive to individual muscarinic receptors [17] [18] [19] , p-fluorohexahydrosiladifenidol, an inhibitor sensitive to M $ muscarinic receptor, was sufficient to block the carbachol-induced activation of Erk-1 and -2 ( Figure 2A ), suggesting that M $ muscarinic receptor mediated carbacholinduced Erk-1 and -2 activation in SK-N-BE2(C) cells. This was further confirmed by treating cells with various concentrations of antagonists, with carbachol and by investigating the order of potency of the inhibitory effects on carbachol-induced Erk-1\-2 activation. As shown in Figure 2 (B), the inhibition of Erk-2 activation was concentration-dependent with each antagonist. The order of potency of the inhibitory effects was : atropine l p-fluorohexahydrosiladifenidol pirenzepine l methoctramine. Similar effects of antagonists on the activation of Erk-1 were observed, and the antagonists themselves had no effect on Erk-1\-2 activation (results not shown). We therefore concluded that carbachol-induced Erk activation was primarily mediated by M $ muscarinic receptor in SK-N-BE2(C) cells.
Figure 1 Carbachol induces activation of Erk-1 and -2 in SK-N-BE2(C) cells
(A) The cells were treated with 1 mM carbachol for the indicated time periods. Activation of Erk-1 and -2 was examined by determining its phosphorylation using antibody specific to phosphorylated Erk-1 and -2 (pErk). Upper and lower bands represent phosphorylated Erk-1 and -2 respectively. Protein levels of total Erk-1 and -2 were determined by Western blotting using the same lysate separated by 7.5 %-polyacrylamide gel. Note that both Erk-1 and -2 appear as a single band under these conditions. (B) Activation of Erk-1 and -2 was determined by mobilityshift assay in 10 %-polyacrylamide gel as described in the Experimental section. 
Carbachol-induced Erk-1/-2 activation depends on Ras, Raf and MEK
In an attempt to elucidate signalling pathways leading to the activation of Erk-1\-2, we first examined the role of MEK, which is known to directly activate Erk by dual phosphorylation on threonine and tyrosine residues [20] . Carbachol-induced activation of Erk-1\-2 was inhibited in a dose-dependent manner by pretreatment of the cells with a specific inhibitor of MEK, PD98059 ( [21] ; results not shown). Since MEK is known to be activated by phosphorylation via MEK kinase (MEKK) [20, 22] , we next examined the role of c-Raf-1, the best characterized MEKK [23] . Raf kinase activity in the cells treated with carbachol was directly measured using immunoprecipitated Raf and MEK-1 as a substrate for Raf. As shown in Figure 3 forskolin prior to the stimulation of the cells with carbachol, since forskolin is known to induce inhibitory phosphorylation of Raf by activating protein kinase A [24, 25] . Under the present conditions, carbachol-induced activation of Raf ( Figure 3A ) and Erk-2 ( Figure 3B ) was significantly inhibited. The amounts of immunoprecipitaed or expressed c-Raf-1 in the absence or presence of forskolin were practically the same (results not shown). Taken together, the results indicated that Raf activity was required for MEK-dependent Erk-2 activation.
It has been known for some time that stimulation of M # muscarinic receptor by carbachol leads to the activation of Erk via PI 3-kinase and Ras [9, 10] . We therefore posed the question of whether M $ muscarinic receptor used the same signalling molecules for the activation of Erk-1 and -2 by an ectopic expression of inhibitory Ras, RasN17, since expression of RasN17 has been demonstrated to block Ras-mediated growthfactor signalling [16] . As Figures 4(A) and 4(B) show, carbacholinduced phosphorylated Erk-2 in RasN17-expressing cells was approx. 30 % of that in the control, suggesting that Ras was required for Erk activation. The partial inhibition of Erk-2 activation by RasN17 might be due to incomplete transfection of cDNA, although the expression of Ras increased more than 10-fold ( Figure 4C ). Ras activity also appeared to be required for the activation of Raf, because the expression of RasN17 blocked carbachol-induced Raf activity ( Figure 4D ). The expression of RasN17 did not affect the expression level of Erk-2 nor Raf (results not shown). In contrast with the role of Ras, carbacholinduced Erk signalling was not significantly affected by the treatment of the cells with specific inhibitors of PI 3-kinase o400 nM wortmannin [26] and 50 µM LY294002 ( [27] ; data not shown)q, suggesting that M $ muscarinic receptor activated Erk in a PI 3-kinase-independent pathway.
PKCε mediates Ras, Raf and MEK-dependent Erk activation
In human SH-SY5Y neuroblastoma cells [11] and oligodendrocytes [12] it has been suggested that PKC is required for Erk activation upon the stimulation of M $ muscarinic receptor. We, therefore, examined whether carbachol activated Erk in SK-N-BE2(C) cells by modulating PKC activity. Carbachol-induced activation of Erk-2 was completely inhibited by preincubation of the cells with GF109203X, an inhibitor of PKC [28] , or downregulation of PKC with prolonged treatment of PMA ( Figure 5 ).
PKC is a multigene protein kinase family composed of 11 known isoforms [7] . SK-N-BE2(C) cells expressed α, ε, ζ, λ\ι, and µ isoforms of PKC ( Figure 6A ), while other PKC isoforms (i.e., β, γ, δ, θ, and η) were hardly detectable by Western blotting (results not shown). We therefore examined which PKC isoforms were activated in Erk signalling in carbachol-treated cells. Activation of PKC was determined by examining translocation of cytosolic PKC to a particulate membrane fraction, because PKC activation involves a stable association of PKC with membranes [29, 30] . As shown in Figure 6 (A), PKCα and PKCζ were detected predominantly in the cytosolic fraction of the untreated cells, whereas the ε, λ\ι, and µ isoforms were mainly in the cytosolic fraction with a significant amount in the particulate membrane fraction. As expected, treatment of the cells with PMA induced translocation of cytosolic α and ε isoforms to the particulate membrane fraction with a concomitant decrease from the cytosolic fraction. The distributions of PKCζ, PKCλ\ι and PKCµ were not altered by PMA treatment. When the cells were treated with carbachol, relative distributions of PKCα, PKCζ, PKCλ\ι and PKCµ were not changed. However, the level of PKCε in the cytosolic fraction was significantly decreased, with a concomitant increase in the membrane fraction ( Figure 6A ). Redistribution of PKCε was detectable as early as 2.5 min after the carbachol treatment ( Figure 6B ), as determined by measuring time-dependent translocation of cytosolic PKC isoforms to the particulate membrane. Distribution of PKCα ( Figure 6B ) and other isoforms (results not shown) was not affected throughout the time periods examined. The results indicated that only PKCε, among the expressed multiple PKC isoforms, was specifically activated by carbachol treatment and might be involved in Erk-1\-2 activation.
The role of PKCε in carbachol-induced Erk activation was further examined by selective down-regulation of PKC isoforms. As shown in Figure 7(D) , chronic exposure of SK-N-BE2(C) cells to PMA or thymeleatoxin induced down-regulation of PKCα and PKCε, and the activation of Erk was significantly blocked under the conditions used ( Figure 7C ). Prolonged treatment of the cells with ingenol 3,20-dibenzoate induced selective down-regulation of PKCε without affecting other isoforms ( Figure 7D) , and down-regulation of PKCε alone was sufficient to block Erk-2 activation ( Figure 7C ). In addition, treatment of the cells with Go6976, which inhibits conventional PKC isoforms such as PKCα and PKCβ [31] , did not affect Erk-2 activation ( Figure 7E ). Taken together, our results strongly suggest that PKCε is the responsible isoform for carbacholinduced Erk activation in SK-N-BE2(C) cells.
Finally, we examined at which step in the carbachol-treated cells PKCε activated Erk-1 and -2. As Figure 7 (A) shows, carbachol-induced activation of Raf was blocked by the inhibition of PKC with GF109203X, but the inhibition of Raf with forskolin did not affect translocation of PKCε ( Figure 7B ), although Erk-2 activation was blocked (Figure 3 ). This indicated that PKCε acted upstream of Raf in the MAP kinase signalling cascade. In addition, carbachol-induced translocation of PKCε was not affected by the expression of RasN17 ( Figure 7B ), and Ras was required for the activation of Raf ( Figure 4D ). These results suggested that PKCε was activated before the sequential activation of Ras, Raf and MEK.
DISCUSSION
Erk-1 and -2, members of the MAP kinase family, are common intermediates in intracellular signalling cascades involved in diverse cellular functions [20, 22] . MAP kinase is activated by phosphorylation on both threonine and tyrosine by MEK upon stimulation of various cell-surface receptors such as receptor tyrosine kinase, G-protein-linked receptors and cytokine receptors [20, 22] . The receptor tyrosine kinase is relatively well characterized and requires sequential action of Grb2\Sos, Ras, Raf and MEK for the activation of MAP kinase [20, 22] . Additionally, PKC appears to regulate MAP kinase signalling, because a direct stimulation of PKC with phorbol ester leads to the activation of MAP kinase [32, 33] .
In the present study we elucidated a signalling pathway leading to the activation of Erk-1 and -2 upon stimulation of G-proteinlinked M $ muscarinic receptor. As summarized in Scheme 1, our data indicate that PKCε mediates Ras-, Raf-and MEK-dependent activation of MAP kinase. The signalling pathway from the activation of PKCε to Ras activation has not yet been clarified. However, PI 3-kinase does not seem to be involved in MAP kinase signalling in SK-N-BE2(C) cells, because inhibition of PI 3-kinase with wortmannin and LY294002 does not affect carbachol-induced Erk-2 activation (results not shown). Furthermore, we cannot detect immunochemically any association between Shc, Grb2, and Sos during carbachol stimulation of SK-N-BE2(C) cells (results not shown) : These signalling molecules (i.e., PI 3-kinase, Shc, Grb2 and Sos) are required for the G βγ -dependent activation of MAP kinase by the stimulation of M # muscarinic receptor ( [9, 10] ; Scheme 1).
Our results, summarized in Scheme 1, indicate that PKCε was activated before the activation of Ras. The evidence included the observations that : (1) carbachol-induced translocation of PKCε was not affected by the expression of RasN17 ( Figure 7B) ; (2) overexpression of RasN17 significantly decreased carbacholinduced Raf activation ( Figure 4D) ; and (3) carbachol-induced activation of Raf was blocked by the inhibition of PKC with GF109203X, but the inhibition of Raf with forskolin did not affect translocation of PKCε ( Figure 7B ). However, activation of
Scheme 1 Comparison of signalling pathway leading to Erk activation initiated by M 2 and M 3 muscarinic receptors
Erk activation by a stimulation of M 2 muscarinic receptor with carbachol is mediated by G βγ -dependent activation of PI 3-kinase that sequentially activates Shc, Grb2, Sos, Ras, Raf, and MEK [9] . In contrast, stimulation of M 3 muscarinic receptor with carbachol induces activation of G-protein-linked PLC that produces diacylglycerol and InsP 3 [6] . Diacylglycerol in turn selectively activates PKCε among the expressed PKC isoforms. The activated PKCε stimulates Ras via an as-yet-unknown signalling pathway to sequentially activate Raf, MEK and Erk-1/2.
Raf and Erk-2 was not completely inhibited by the overexpression of RasN17. Although this raises the possibility that PKCε may directly activate Raf, we are inclined to believe that this is due to incomplete transfection of cDNA. Indeed, transient transfection resulted in an overexpression of RasN17 in about 70 % of cells as determined by immunofluorescence microscopy (results not shown), although the total level of Ras increased more than 10-fold as determined by Western blotting ( Figure 4C ).
PKC is a large family composed of 11 known isoforms, each of which exhibits unique characteristics [7, 29, 30] . Individual PKC isoforms are activated in different ways, which variably depend on Ca# + and various membrane lipid mediators, and they play distinct roles in the control of physiological functions. The multiplicity of PKC isoforms suggests that they are responsible for a wide variety of specialized physiological processes ; however, direct evidence assigning any specific function to any specific isoform is scarce. The difficulty lies in the fact that most cells express multiple isoforms which may be regulated individually and which may interact or ' cross-talk '. SK-N-BE2(C) cells expressed multiple PKC isoforms such as α, ε, ζ, λ\ι, and µ. Among the expressed isoforms, only PKCε was found to be activated by the treatment of carbachol ( Figure 6 ). Activation of PKC in carbachol-treated SK-N-BE2(C) cells was expected, because carbachol stimulation induced activation of PLC to generate diacylglycerol and to mobilize Ca# + [6, 7] , and only Ca# + -independent PKCε was activated by carbachol treatment ( Figure  6 ). Regulation of PKC activation is a complex process that requires generation of second messengers, including diacylglycerol and Ca# + , phosphorylation of PKC by a putative kinase, Received 22 June 1998/6 October 1998 ; accepted 30 October 1998 and targeting proteins [7, 29, 30] . This might explain why Ca# + -dependent PKCα was not activated in carbachol-treated cells, although carbachol increased the cytosolic free Ca# + level [6] . Alternatively, it is possible that carbachol affected the activity of other PKC isoforms ; however, this is not detected by the classical translocation assay. The observation that selective down regulation of PKCε is sufficient to block carbachol-induced MAP kinase activation ( Figure 6 ) strongly indicates that PKCε is the only responsible isoform in carbachol-induced MAP kinase activation in SK-N-BE2(C) cells.
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